Safety and antibody response after one and/or two doses of BNT162b2 Anti‐SARS‐CoV‐2 mRNA vaccine in patients treated by CAR T cells therapy

Thomas Gastinne; Amandine Le Bourgeois; Marianne Coste‐burel; Thierry Guillaume; Pierre Peterlin; Alice Garnier; Berthe‐marie Imbert; Thomas Drumel; Beatrice Mahe; Viviane Dubruille; Nicolas Blin; Anne Lok; Cyrille Touzeau; Benoit Tessoulin; Maxime Jullien; Sophie Vanthygem; Marie C Béné; Philippe Moreau; Steven Le Gouill; Patrice Chevallier

doi:10.1111/bjh.17818

Journal Articles British Journal of Haematology Year : 2021

Safety and antibody response after one and/or two doses of BNT162b2 Anti‐SARS‐CoV‐2 mRNA vaccine in patients treated by CAR T cells therapy

(1) , (1) , (1) , (1, 2) , (1) , (1) , (1) , (1) , (1) , (1) , (1) , (1) , (1) , (1) , (1) , (1) , (1) , (1) , (1) , (1, 3)

1
2
3

Thomas Gastinne

Function : Author

Centre hospitalier universitaire de Nantes

Amandine Le Bourgeois

Function : Author

Centre hospitalier universitaire de Nantes

Marianne Coste‐burel

Function : Author

Centre hospitalier universitaire de Nantes

Thierry Guillaume

Function : Author
PersonId : 766700
ORCID : 0000-0001-5482-8565

Centre hospitalier universitaire de Nantes

Centre de Recherche en Cancérologie et Immunologie Nantes-Angers

Pierre Peterlin

Function : Author
PersonId : 776625
ORCID : 0000-0001-5463-6686

Centre hospitalier universitaire de Nantes

Alice Garnier

Function : Author

Centre hospitalier universitaire de Nantes

Berthe‐marie Imbert

Function : Author

Centre hospitalier universitaire de Nantes

Thomas Drumel

Function : Author

Centre hospitalier universitaire de Nantes

Beatrice Mahe

Function : Author

Centre hospitalier universitaire de Nantes

Viviane Dubruille

Function : Author

Centre hospitalier universitaire de Nantes

Nicolas Blin

Function : Author

Centre hospitalier universitaire de Nantes

Anne Lok

Function : Author

Centre hospitalier universitaire de Nantes

Cyrille Touzeau

Function : Author
PersonId : 778761
ORCID : 0000-0003-0275-2575

Centre hospitalier universitaire de Nantes

Benoit Tessoulin

Function : Author
PersonId : 1040919
ORCID : 0000-0001-7600-3329
IdRef : 195047265

Centre hospitalier universitaire de Nantes

Maxime Jullien

Function : Author
PersonId : 808174
ORCID : 0000-0001-6915-6570

Centre hospitalier universitaire de Nantes

Sophie Vanthygem

Function : Author

Centre hospitalier universitaire de Nantes

Marie C Béné

Function : Author
PersonId : 767851
ORCID : 0000-0002-6569-7414

Centre hospitalier universitaire de Nantes

Philippe Moreau

Function : Author
PersonId : 759214
ORCID : 0000-0003-1780-8746

Centre hospitalier universitaire de Nantes

Steven Le Gouill

Function : Author
PersonId : 761203
ORCID : 0000-0001-9840-2128

Centre hospitalier universitaire de Nantes

Patrice Chevallier

Function : Author
PersonId : 762210
ORCID : 0000-0003-3142-5581

Centre hospitalier universitaire de Nantes

Immunobiology of Human αβ and γδ T Cells and Immunotherapeutic Applications

Abstract

No abstract available

Keywords

BNT162b2 CAR-T cells COVID 19 SARS-CoV-2 mRNA vaccine

Domains

Cancer

Embargoed file

Ne sera jamais visible

Elizabeth Bernardo : Connect in order to contact the contributor

https://www.hal.inserm.fr/inserm-03388040

Submitted on : Wednesday, October 20, 2021-10:50:46 AM

Last modification on : Friday, March 24, 2023-2:53:23 PM

Long-term archiving on: Friday, January 21, 2022-7:28:28 PM

Dates and versions

inserm-03388040 , version 1 (20-10-2021)

Identifiers

HAL Id : inserm-03388040 , version 1
DOI : 10.1111/bjh.17818
PUBMED : 34476803

Cite

Thomas Gastinne, Amandine Le Bourgeois, Marianne Coste‐burel, Thierry Guillaume, Pierre Peterlin, et al.. Safety and antibody response after one and/or two doses of BNT162b2 Anti‐SARS‐CoV‐2 mRNA vaccine in patients treated by CAR T cells therapy. British Journal of Haematology, 2021, Online ahead of print. ⟨10.1111/bjh.17818⟩. ⟨inserm-03388040⟩

Export

BibTeX TEI Dublin Core DC Terms EndNote Datacite

Collections

INSERM UNIV-NANTES CNRS UNIV-ANGERS CRCINA NANTES-UNIVERSITE

24 View

27 Download

Safety and antibody response after one and/or two doses of BNT162b2 Anti‐SARS‐CoV‐2 mRNA vaccine in patients treated by CAR T cells therapy

Abstract

Keywords

Domains

Dates and versions

Identifiers

Cite

Export

Collections

Altmetric

Share